国家联合资源(00254.HK):上市覆核委员会聆讯于2020年1月15日举行
格隆汇11月25日丨国家联合资源(00254.HK)公布,於2019年11月13日,公司以程序不公为由,就联交所上市委员会之除牌决定向香港高等法院提交司法覆核许可申请。
司法覆核申请的依据是基於联交所无视公司出席上市委员会聆讯和陈词之要求,及在公司缺席情况下于2019年8月29日在上市委员会聆讯上作出将公司股份除牌之决定。
上市覆核委员会聆讯原订于2020年1月8日举行。公司已向上市覆核委员会提出进一步延期要求,而上市覆核委员会聆讯现订于2020年1月15日举行。
此外,公司股份继续停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.